Regularly compiles ratings and target prices for US stocks and China concept stocks from various brokerages.
June 24 News: The following are the latest ratings and target prices for US stocks from various brokerages:
CICC maintains an Outperform industry rating for Snowflake Inc (SNOW.N) with a target price of $280:
AI-driven revenue growth is accelerating, with Q1 FY27 revenue up 33% year-over-year, exceeding expectations, and product revenue up 34%. The company is building a unified intelligent agent control plane to empower enterprise applications with AI large models, while improving efficiency and maintaining stable margins through AI. Revenue and profit forecasts for FY27/FY28 are raised, and the target price is based on 17x FY27 price-to-sales ratio, implying 21% upside from the current level.
CICC gives Merck & Co (MRK.N) an Outperform industry rating with a target price of $138.00:
The company is a global pharmaceutical leader, with strong Keytruda sales, and blockbuster pipelines such as Sac-TMT are expected to drive growth. Adjusted EPS for 2027 is estimated at $9.52, current valuation is only 12x, and the target price corresponds to 15x P/E, implying 21% upside.
